Investigation of antimicrobial activities of bioactive compound against Pseudomonas aeruginousa isolated from burns infections

Forty-five samples in total there are just twenty isolates of Pseudomonas aeruginousa. Over the period of four months, from January 2025 to April 2025, a variety of clinical samples were gathered from numerous hospitals in Baghdad, including Al-Sader, Ibn Al-Balady, Fatima Al-Zahraa, and Al-Imam Ali Hospitals. The clinical samples of patients with burns infections were included. The Vitek 2 compact and a biochemical test verified that all isolates were cultivated on king A, king B, ctrmide agar, macConkey agar, and blood agar. Using the disk diffusion technique, the susceptibility of P. aeruginousa isolates to 16 antibiotics from various classes was determined. P. aeruginousa isolates exhibited strong resistance to the majority of the antibiotics under investigation, according to the findings of the sensitivity test. Numerous Aspergillus terreus bioactive extract compounds that were extracted from soil showed antibacterial activity. Through a number of signal transduction pathways, secondary metabolites activate the host's defenses. At varying concentrations, the bioactive molecule showed high levels of efficacy against P. aeruginousa isolates from burns.